CrowdfundedWealth

Manulife Private Credit Plus Fund Tender Offer, December 2026

ResearchBy Jorge21 min read18 SEC filings cited

Some links pay us a referral fee; each one says so. Disclosure

Quick answer

Manulife Private Credit Plus Fund (SEC CIK 1988855, Class I ticker MPIDX) filed a Schedule TO-I on November 18, 2026 offering to buy back up to $12.17 million of its shares, “approximately 5% of the net assets of the Fund as of July 31, 2026”. Holders must send a Letter of Transmittal by 11:59 p.m. Eastern on December 18, 2026, the same minute the right to withdraw ends; the price is the NAV per share on December 31, 2026, and a tender the fund has not accepted by January 15, 2027 at the latest can be withdrawn (accession 0001193125-26-466750). The offer cites net assets of $243,797,553.01 and a NAV of $19.92 at July 31, 2026; the last NAV in any filing is $19.67 at September 30, 2026 (Schedule TO-I/A, accession 0001193125-26-452963). Of five earlier offers, three drew no shares, one drew $10,382.87 and one drew $11.0 million against $9.9 million offered, all of which the fund accepted. This fund is neither the survivor nor the absorbed side of the Manulife merger: it was the largest holder of the absorbed Manulife Private Credit Fund (69.9% at June 30, 2026) and now owns about 23% of the survivor, John Hancock Comvest Private Income Fund.

Key takeaways

  • The offer is cash, not a note. The Offer to Repurchase says the fund pays from “cash on hand; (b) the distribution of securities in-kind or partly in cash and partly in-kind; or (c) borrowings”, with no interest, and deducts the month's accrued management fee before it buys. John Hancock Comvest Private Income Fund (JHCPIF) filed its own offer the same day, and it pays with a non-interest-bearing promissory note.
  • The price is not known when you tender. The valuation date is December 31, 2026, thirteen days after the December 18, 2026 deadline (our arithmetic). The last NAV on file is $19.67 at September 30, 2026, down from $20.11 at December 31, 2025, which is 2.2% lower (our arithmetic). The fund may cancel, amend or postpone if its NAV falls materially from the one on the commencement date.
  • Only one of five earlier offers was oversubscribed. In the offer valued March 31, 2026, holders tendered $11,000,000 (550,826.24 shares at $19.97) against $9.9 million offered, and the fund bought all of it, 111.1% of the offer (our arithmetic). The offers valued September 2025, December 2025 and June 2026 drew nothing; the one valued September 30, 2026 drew 527.853 shares, $10,382.87, or 0.10% of the $10.91 million offered (our arithmetic).
  • Few outside holders can be tendering. The offer names five holders linked to John Hancock or Manulife with 80.53% of the shares on July 31, 2026 (our sum), the semiannual report says affiliates owned 100% of Class I on June 30, 2026, and the proxy of May 7, 2026 lists a Puerto Rico trust company, acting as trustee, with 13.3% on March 23, 2026. At most 19.47% is held by anyone else, about $47.5 million on July 31, 2026 net assets (our arithmetic).
  • The link to the Manulife merger is ownership. At June 30, 2026 the fund held 5,773,119 shares of Manulife Private Credit Fund worth $118,154,837, 69.9% of that fund and 53.5% of its own net assets (our arithmetic). After the September 30, 2026 merger the 10-Q of JHCPIF shows it owning 6,266,908 JHCPIF Class I shares (the Schedule 13G/A says 6,396,115, 23%), worth about $157.8 million at $25.18 (our arithmetic).
  • It is a fund of funds, and costs sit at two levels. The May 1, 2026 prospectus puts Class I total annual expenses at 3.08%, or 2.75% after waivers, of which 1.46% is acquired fund fees; that figure was set before the merger. Class I needs $25,000 to start and is generally sold through wrap accounts, advisers and similar channels.

CSV · 121 rows

Manulife Private Credit Plus Fund: the November 2026 tender offer, five earlier offers and their results, holders, NAV, holdings and its stake in the merged fund

121 rows from the Schedule TO-I of November 18, 2026 and its exhibits, the five earlier Schedules TO-I and final amendments, the 2025 and 2026 shareholder reports, the May 2026 proxy and prospectus, the Schedule 13G/A of October 1, 2026 and JHCPIF's 10-Q. One accession number per row.

The offer, term by term

Filing alert · free

An email when Manulife Private Credit Plus Fund files with the SEC

An email the day Manulife Private Credit Plus Fund files something new, with the link to the document on the SEC site.

The offer has three parts: the Schedule TO-I, a cover letter, the Offer to Repurchase and a form of Letter of Transmittal. The tender window opened November 18, 2026. Nothing in it is a recommendation: the Offer to Repurchase says in capitals that neither the fund, its adviser nor its board makes one.

TermWhat the offer saysWhere
AmountUp to $12.17 million, about 5% of net assets at July 31, 2026 ($243,797,553.01); 4.99% of that figure (our arithmetic)Schedule TO-I, Items 1 and 4
SharesClass I only; Class S and Class D “are not currently offered and have no assets”Schedule TO-I, Item 1
PriceNAV per share at the Repurchase Valuation Date, December 31, 2026; $19.92 was the July 31, 2026 NAVOffer, Sections 1 and 2
Deadline to tender11:59 p.m. Eastern, December 18, 2026 (the Notice Date)Offer, important dates
Deadline to withdraw11:59 p.m. Eastern, December 18, 2026 (the Expiration Date); also after the Acceptance Date if the fund has not accepted the tenderOffer, Section 5
Acceptance DateNo later than January 15, 2027; after the 40th business day from commencement an unaccepted tender can be withdrawnOffer, important dates
PaymentCash on hand, in-kind distribution of securities (whole or in part) or borrowings; no interestOffer, Section 6
Fees on tendered sharesNone named in the offer; the month's accrued management fee is deducted from assets before the repurchaseOffer, Section 6
If oversubscribedThe fund may accept more under Rule 13e-4(f)(1), extend and enlarge the offer, or take tenders pro rata by NAVOffer, Section 3
Cancel or postponeAllowed up to the Acceptance Date, including on a material fall in NAV from the Commencement DateOffer, Section 7
Who to send it toJohn Hancock Alt, P.O. Box 219285, Kansas City, MO 64121-9285, or by fax or email; broker-held shares go through the brokerLetter of Transmittal
Plans for the fundNo plan for a merger, reorganization or liquidationSchedule TO-I, Item 6

Two details are easy to miss. First, the notice date and the expiration date are the same minute, so a tender sent on the last day cannot later be changed except through the Acceptance Date right; the Letter of Transmittal says “Except as stated in Section 5 of the Offer to Repurchase, this tender is irrevocable.” Second, a holder who tenders all shares “will remain a Shareholder in the Fund through the Repurchase Valuation Date”, so the NAV that sets the price is struck after the money is committed.

A holder reading the earlier pages of ours will also notice what is absent. We found no early repurchase fee in the Offer to Repurchase, which lists the management fee as the only deduction before the buyback, and no promissory note: JHCPIF's offer of the same day uses one (“a non-interest bearing, non-transferable promissory note”), this fund's does not. See our page on the JHCPIF and Manulife merger for how JHCPIF's own offer works.

How this fund relates to the Manulife merger

According to the filings, this fund is neither the surviving fund nor the acquired one. It is a separate fund of funds that was the largest shareholder of the acquired Manulife Private Credit Fund (MPCF), and since September 30, 2026 it is a 23% shareholder of the survivor, John Hancock Comvest Private Income Fund (JHCPIF). Our merger page lists the three holders of MPCF and names “Manulife Private Credit Plus Fund” at 70%; that is this fund, a registered fund whose Class I shares the prospectus says can be bought through advisers and wrap programs, not only a Manulife balance sheet.

ItemFigureSource
MPCF shares held, June 30, 20265,773,119, value $118,154,837 (about $20.47 a share, our arithmetic)Form N-CSRS
Share of MPCF net assets held69.9%Form N-CSRS, note on affiliated funds
Share of this fund's net assets in MPCF53.5% (our arithmetic: 118,154,837 over 220,966,388)Form N-CSRS
Income received from MPCF, six months to June 30, 2026$5,075,611 of $9,034,041 dividends from affiliated fundsForm N-CSRS
Exchange ratio at closing, September 30, 20260.7955 JHCPIF Class I share per MPCF shareJHCPIF Form 10-Q
JHCPIF shares from the exchange (our arithmetic)4,592,516 (5,773,119 times 0.7955)N-CSRS, 10-Q
JHCPIF shares owned, December 31, 2025791,452JHCPIF Form 10-Q
JHCPIF shares owned, September 30, 20266,266,908 per the 10-Q; 6,396,115 per the Schedule 13G/AJHCPIF Form 10-Q; Schedule 13G/A
Share of JHCPIF Class I23% (27,078,712 shares outstanding)Schedule 13G/A; 10-Q

The filings give two share counts for the same date and do not say why. The 10-Q figure of 6,266,908 can be rebuilt almost exactly: 791,452 shares held before, plus 4,592,516 from the exchange, plus 882,822 that fits the July 1, 2026 JHCPIF subscription of 1,480,670 shares less the 597,848 shares the 10-Q shows for John Hancock Reassurance Company Ltd., comes to 6,266,790, which is 118 shares short (our arithmetic). That also fits the rise in this fund's net assets from $220,966,388 at June 30, 2026 to $243,797,553.01 at July 31, 2026, $22.8 million (our arithmetic). The filings do not say the cash went into JHCPIF; it is our reading. The Schedule 13G/A figure is 129,207 shares higher than the 10-Q's (our arithmetic).

What it means for a holder: the 6,266,908 JHCPIF shares are worth about $157.8 million at $25.18, which is 65% of the $243.8 million of net assets cited at July 31, 2026 (our arithmetic; the two dates differ). The offer itself says nothing about the merger beyond Item 6, which reports no plan for a merger or liquidation of this fund.

Five offers with results, and the sixth now open

Each offer is filed with a Schedule TO-I and closed with a final amendment that gives the amount tendered. The notice date and expiration date were the same day in all of them.

Offer filedValuation dateOfferedNet assets citedNAV usedTendered and acceptedOffer / result accession
Aug 21, 2025Sep 30, 2025$9.77M$195,323,560.40 (May 31, 2025)$20.27$00001193125-25-185205 / 0001193125-25-248533
Nov 21, 2025Dec 31, 2025$9.9M$198,294,125.74 (Jul 31, 2025)$20.11$00001193125-25-290787 / 0001193125-26-030801
Feb 20, 2026Mar 31, 2026$9.9M$197,777,600.86 (Sep 30, 2025)$19.97$11,000,000 (550,826.24 shares)0001193125-26-060390 / 0001193125-26-210756
May 18, 2026Jun 30, 2026$11.4M$227,896,310.84 (Dec 31, 2025)$19.89$00001193125-26-228300 / 0001193125-26-339319
Aug 19, 2026Sep 30, 2026$10.91M$228,836,709.62 (Mar 31, 2026)$19.67$10,382.87 (527.853 shares)0001193125-26-356450 / 0001193125-26-452963
Nov 18, 2026Dec 31, 2026$12.17M$243,797,553.01 (Jul 31, 2026)$19.92 at Jul 31Open until Dec 18, 20260001193125-26-466750 / none yet

The “net assets cited” dates come from the sentence in each offer that says the value of the shares may change between that date and the valuation date, so they lag the offer by three to five months. The November offer is the first to cite a date as recent as July 31, 2026. The offered amount has risen from $9.77 million in August 2025 to $12.17 million now, 24.6% more, while the net assets cited rose 24.8%, from $195.3 million to $243.8 million (our arithmetic).

The March 2026 offer is the one to study. Holders asked for $11,000,000, 11.1% more than the $9.9 million offered, and the final amendment reports the whole amount as “tendered and accepted”, without saying whether the fund used the extra shares Rule 13e-4(f)(1) lets it accept, enlarged the offer or prorated. Our arithmetic says the extra $1.1 million is about 55,000 shares, under 0.5% of the shares then outstanding. The semiannual report confirms the cash: $11,000,000 repurchased and 550,826 shares retired in the six months to June 30, 2026, against nothing in 2025. Who tendered is not in the filings. The August 2026 final amendment, filed November 9, 2026, shows the opposite: 527.853 shares.

Timing of the result is predictable. The five final amendments were filed 23 to 40 days after the valuation date (our arithmetic from the signing dates), so a result for this offer would be expected between about January 23 and February 9, 2027, a pattern and not a deadline.

Who holds the fund

Class I shares can be bought through fee-based wrap accounts, registered investment advisers, participating broker-dealers with alternative fee arrangements, by institutions and charities and by the adviser's people, with a $25,000 minimum that may be waived. The fund's holders look very different from that list.

HolderShare, July 31, 2026 (Schedule TO-I)Share, March 23, 2026 (proxy)
John Hancock Stable Value Fund Collective Investment Trust, Global Trust Company as trustee44.57%23.0% and 20.5% (the proxy lists the trust under two names)
Manulife Reinsurance (Bermuda)17.98%21.6%
John Hancock Life & Health Insurance Company7.19%8.6%
John Hancock Life Insurance Company of New York7.19%8.6%
John Hancock Life Insurance Company (USA)3.60%not listed
A Puerto Rico trust company, as trusteenot named13.3%
Listed in the offer, total (our sum)80.53%not summed

The offer says none of the portfolio managers or officers held shares on July 31, 2026, and calls each of the five named holders an affiliate of the adviser. The semiannual report is blunter: “Affiliates of the fund owned 100% of shares of Class I on June 30, 2026.” The annual report said the same for December 31, 2025. Those statements and the proxy table cannot all be read as one list of owners, and the filings do not reconcile them. What can be said is that most of the capital behind a $12.17 million offer belongs to insurance companies and a stable-value collective investment trust, so an individual who owns shares is likely a small part of the register.

That matters for the size of the offer. If the 19.47% that the offer does not name were all held by outsiders it would be about $47.5 million, and $12.17 million would be 25.6% of it (our arithmetic, a ceiling and not a count). Any named holder can tender as well, and the filings say only that the fund's affiliates made no transactions in the 60 days before the offer other than reinvesting dividends.

DateNet assetsClass I NAVShares outstandingSource
Dec 31, 2024$99,908,771$20.184,951,449Form N-CSRS
Dec 31, 2025$230,438,199$20.1111,458,730Form N-CSRS
Jun 30, 2026$220,966,388$19.86 ($19.89 in the May 2026 offer result)11,126,738Form N-CSRS; Schedule TO-I/A
Jul 31, 2026$243,797,553.01$19.92not stated (about 12.24 million, our arithmetic)Schedule TO-I
Sep 30, 2026not on file$19.67not on fileSchedule TO-I/A

Two documents give different NAVs for June 30, 2026: $19.86 in the shareholder report and $19.89 in the final amendment of the May 2026 offer; we show both. The fund sold $125,010,000 of shares in 2025 and none for cash in the first half of 2026, per the statement of changes in net assets, and net assets then rose by $22.8 million between June 30 and July 31, 2026 (our arithmetic).

Income per share was $0.69 and distributions $0.66 for the six months to June 30, 2026, against $1.47 and $1.37 for 2025, so distributions ran at about 6.6% of the June 30 NAV on an annual basis (our arithmetic: 0.66 times two over 19.86). Distributions payable at June 30, 2026 were $1,340,738. Net investment income per share is affected, the report says, by the timing of the dividends of the funds it owns.

Costs are in two layers. The fund pays a 1.25% management fee on monthly net assets; its expense ratio was 1.32% after reductions in the first half of 2026, and that excludes what the underlying funds charge. The May 1, 2026 prospectus adds 1.46% of acquired fund fees and expenses to reach 3.08% for Class I (2.75% after waivers). After the merger much of the money sits in JHCPIF, so the next prospectus update will show the new figure; we do not estimate it.

What it owns

At June 30, 2026 the fund had 97.2% of net assets in affiliated investment companies, 4.5% in two bond ETFs and 1.6% in commercial paper.

Holding, June 30, 2026SharesValueShare of net assets
Manulife Private Credit Fund (absorbed September 30, 2026)5,773,119$118,154,83753.5% (our arithmetic)
John Hancock Marathon Asset-Based Lending Fund, Class I3,394,958$66,812,78030.2%
John Hancock Comvest Private Income Fund, Class I791,452$19,857,5399.0% (our arithmetic)
Two John Hancock bond ETFs461,795 (our sum)$9,990,7784.5%
Commercial papern/a$3,487,9361.6%

Business development companies were 62.5% of net assets and alternative and specialty funds 30.2%. The fund held 23.5% of the net assets of the Marathon fund at the same date. For the structure of JHCPIF, the survivor, and its own record of offers, see our page on the merger; for how this compares with other credit tender funds, see Fidelity Private Credit Fund and BlackRock Private Credit Fund, and for the wider list, private credit funds.

What a reader can do with this

  • If you received the offer and want out: the filing says to complete the Letter of Transmittal so it is received by 11:59 p.m. Eastern on December 18, 2026; if your shares are at a broker or custodian, their paperwork has to reach the transfer agent by the same minute or the request is “not in good order”. You can change your mind until that minute. Ask the transfer agent (SS&C GIDS, (844) 292-8018) for an estimated NAV; the price will be the December 31, 2026 NAV, not the July 31, 2026 figure.
  • If you are weighing how much you might sell: the offer is $12.17 million. In March 2026 holders asked for 111.1% of the amount offered and the fund took all of it; in the other four offers the request was between nothing and 0.10%. The filings do not give any rule for what happens if requests are much larger.
  • If you tender: a repurchase may be taxable. The offer describes sale-or-exchange treatment under Code section 302(b) and dividend treatment in other cases, with 24% backup withholding without a taxpayer number; your tax adviser decides which applies to you.
  • If you hold it through a retirement plan or a collective trust: the holders named in the offer include a stable-value collective trust. If your money reaches the fund through a plan or product like that, you are probably not the shareholder of record, so ask whoever runs it before assuming you can tender.
  • What would change the picture: a final amendment showing requests near $12.17 million again, a NAV below $19.67 at December 31, 2026, any notice of cancellation or postponement before January 15, 2027, or a new prospectus that restates the 3.08% cost after the merger.

FAQ

All figures are from SEC EDGAR filings of Manulife Private Credit Plus Fund (CIK 1988855) read on November 19, 2026: the Schedule TO-I of November 18, 2026 with its cover letter, Offer to Repurchase and Letter of Transmittal (accession 0001193125-26-466750); the five earlier Schedules TO-I (0001193125-25-185205, 0001193125-25-290787, 0001193125-26-060390, 0001193125-26-228300, 0001193125-26-356450) and their final amendments (0001193125-25-248533, 0001193125-26-030801, 0001193125-26-210756, 0001193125-26-339319, 0001193125-26-452963); the annual report on Form N-CSR filed March 6, 2026 (0001988855-26-000002) and the semiannual report on Form N-CSRS filed September 1, 2026 (0001988855-26-000019); the prospectus supplement on Form 486BPOS of April 28, 2026 (0001193125-26-186393); the definitive proxy statement of May 7, 2026 (0001193125-26-210732); and the Schedule 13G/A of October 1, 2026 (0001193125-26-410322). The fund's stake in the merged fund and the exchange ratio come from the Form 10-Q of John Hancock Comvest Private Income Fund filed November 12, 2026 (CIK 1987221, 0001193125-26-458730), and its own offer from the Schedule TO-I filed November 18, 2026 (0001193125-26-466045). This is analysis of public documents, not investment, legal or tax advice.

Affiliate Disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This does not affect our ratings. Learn more.